Literature DB >> 24283551

Bronchial and non-bronchial systemic arteries: value of multidetector CT angiography in diagnosis and angiographic embolisation feasibility analysis.

Yuning Lin1, Ziqian Chen, Xizhang Yang, Qun Zhong, Hongwen Zhang, Li Yang, Shangwen Xu, Hui Li.   

Abstract

INTRODUCTION: The aim of this study is to evaluate the diagnostic performance of multidetector CT angiography (CTA) in depicting bronchial and non-bronchial systemic arteries in patients with haemoptysis and to assess whether this modality helps determine the feasibility of angiographic embolisation.
MATERIALS AND METHODS: Fifty-two patients with haemoptysis between January 2010 and July 2011 underwent both preoperative multidetector CTA and digital subtraction angiography (DSA) imaging. Diagnostic performance of CTA in depicting arteries causing haemoptysis was assessed on a per-patient and a per-artery basis. The feasibility of the endovascular treatment evaluated by CTA was analysed. Sensitivity, specificity, and positive and negative predictive values for those analyses were determined.
RESULTS: Fifty patients were included in the artery-presence-number analysis. In the per-patient analysis, neither CTA (P = 0.25) nor DSA (P = 1.00) showed statistical difference in the detection of arteries causing haemoptysis. The sensitivity, specificity, and positive and negative predictive values were 94%, 100%, 100%, and 40%, respectively, for the presence of pathologic arteries evaluated by CTA, and 98%, 100%, 100%, and 67%, respectively, for DSA. On the per-artery basis, CTA correctly identified 97% (107/110). Fifty-two patients were included in the feasibility analysis. The performance of CTA in predicting the feasibility of angiographic embolisation was not statistically different from the treatment performed (P = 1.00). The sensitivity, specificity, and positive and negative predictive values were 96%, 80%, 98% and 67%, respectively, for CTA.
CONCLUSIONS: Multidetector CTA is an accurate imaging method in depicting the presence and number of arteries causing haemoptysis. This modality is also useful for determining the feasibility of angiographic embolisation for haemoptysis.
© 2013 The Authors. Journal of Medical Imaging and Radiation Oncology © 2013 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Keywords:  DSA; embolisation; haemoptysis; multidetector CTA

Mesh:

Substances:

Year:  2013        PMID: 24283551     DOI: 10.1111/1754-9485.12058

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  6 in total

Review 1.  Dieulafoy's disease of the bronchus: report of a case and review of the literature.

Authors:  Yu Fang; Qingchen Wu; Bin Wang
Journal:  J Cardiothorac Surg       Date:  2014-12-02       Impact factor: 1.637

2.  Massive Hemoptysis due to Right Inferior Phrenic Artery-to-Right Pulmonary Artery Fistula in the Right Middle Lobe of the Lung.

Authors:  Emi Yakushiji; Shinichiro Ota; Tomohiro Komatsu; Makoto Ayaori; Katsunori Ikewaki
Journal:  Intern Med       Date:  2017-03-17       Impact factor: 1.271

Review 3.  Evaluation of the bronchial arteries: normal findings, hypertrophy and embolization in patients with hemoptysis.

Authors:  João Almeida; Cecília Leal; Luísa Figueiredo
Journal:  Insights Imaging       Date:  2020-05-19

4.  A retrospective analysis of risk factors in recurrent hemoptysis patients with non-bronchial systematic artery feeding.

Authors:  Jian Zhang; Lili Zheng; Tian Zhao; Shiyong Huang; Wenhao Hu
Journal:  Ann Transl Med       Date:  2020-12

5.  Efficacy of regional arterial embolization before pleuropulmonary resection in 32 patients with tuberculosis-destroyed lung.

Authors:  Gang Chen; Fang-Ming Zhong; Xu-Dong Xu; Guo-Can Yu; Peng-Fei Zhu
Journal:  BMC Pulm Med       Date:  2018-10-01       Impact factor: 3.317

6.  Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis.

Authors:  Jung Han Hwang; Jeong Ho Kim; Suyoung Park; Ki Hyun Lee; So Hyun Park
Journal:  Respir Res       Date:  2021-08-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.